Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
CN Healthy Food Tech Group Corp.Iron Horse Acquisitions Corp. Reports Net Loss of $63,940 for Quarter Ending June 30, 2025
FILANA THERAPEUTICS, INC.Cassava Sciences Reports $44.2 Million Net Loss in Q2 2025, Shifts Focus to Simufilam Development
Candel Therapeutics, Inc.Candel Therapeutics Reports Improved Financial Results for Q2 2025
Xilio Therapeutics, Inc.Xilio Therapeutics Reports $8.1 Million Revenue for Q2 2025, Despite Operating Losses
Zoned Properties, Inc.Zoned Properties Reports 35.4% Revenue Growth in Q2 2025
TaoWeave, Inc.Oblong Reports Q2 2025 Revenue Decline, Strategic Shift Towards Digital Assets
Synergy CHC Corp.Synergy CHC Corp. Reports Q2 2025 Revenue of $8.1 Million, Net Income Increases to $1.5 Million
Sow Good Inc.Sow Good Inc. Reports 88% Revenue Decline and Gross Loss in Latest Quarter
Clene Inc.Clene Inc. Reports 70% Revenue Decline in Q2 2025, Plans for Funding Options
LION COPPER & GOLD CORP.Lion Copper and Gold Corp. Reports $4 Million Net Loss for First Half of 2025
Cocrystal Pharma, Inc.Cocrystal Pharma Reports $2.1 Million Net Loss in Q2 2025, Significant Reduction in Operating Expenses
PALVELLA THERAPEUTICS, INC.Palvella Therapeutics Reports $9.5 Million Net Loss in Q2 2025 Amid Increased R&D Expenses
GBT Technologies Inc.GBT Technologies Inc. Reports $215,554 Net Loss and Faces Financial Challenges in Latest 10-Q
Volato Group, Inc.Volato Group Reports $24.9 Million Revenue and $3.6 Million Net Income in Q2 2025
BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Reports Q2 2025 Financial Results with Improved Net Loss
GALECTIN THERAPEUTICS INCGalectin Therapeutics Reports Reduced Net Loss and Advances Clinical Trials in Q2 2025
Lexeo Therapeutics, Inc.Lexeo Therapeutics Reports $26.1 Million Net Loss in Q2 2025, Highlights Clinical Advancements
Onconetix, Inc.Onconetix Reports 84.9% Revenue Decline and $2.4 Million Net Loss in Latest Quarter
Advanced Flower Capital Inc.Advanced Flower Capital Inc. Reports $13.2 Million Net Loss and Strategic Expansion Plans
ABEONA THERAPEUTICS INC.Abeona Therapeutics Reports $400,000 Revenue and $108.8 Million Net Income for Quarter Ending June 30, 2025
Falcon's Beyond Global, Inc.Falcon's Beyond Reports 42% Revenue Growth and $25.11M Net Income in Q2 2025
Prelude Therapeutics IncPrelude Therapeutics Reports $31.2 Million Net Loss in Q2 2025, Seeks Additional Funding
BK Technologies CorpBK Technologies Reports Revenue Growth and Increased Profitability in Q2 2025
McGraw Hill, Inc.McGraw Hill Reports $535.7 Million Revenue and Net Income Recovery in Q2 2025
TIC Solutions, Inc.Acuren Corporation Reports Q2 2025 Revenue Growth Despite Net Loss